Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.

Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, Menzies D, Horsburgh CR Jr, Crane CM, Burgos M, LoBue P, Winston CA, Belknap R.

Am J Transplant. 2020 Apr;20(4):1196-1206. doi: 10.1111/ajt.15841.

PMID:
32222101
2.

Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries.

Al Abri S, Kasaeva T, Migliori GB, Goletti D, Zenner D, Denholm J, Al Maani A, Cirillo DM, Schön T, Lillebæk T, Al-Jardani A, Go UY, Dias HM, Tiberi S, Al Yaquobi F, Khamis FA, Kurup P, Wilson M, Memish Z, Al Maqbali A, Akhtar M, Wejse C, Petersen E.

Int J Infect Dis. 2020 Mar;92S:S60-S68. doi: 10.1016/j.ijid.2020.02.042. Epub 2020 Feb 27.

3.

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.

Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, Menzies D, Horsburgh CR Jr, Crane CM, Burgos M, LoBue P, Winston CA, Belknap R.

MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1.

4.

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.

Burman M, Copas A, Zenner D, Hickson V, Gosce L, Trathen D, Ashcroft R, Martineau AR, Abubakar I, Griffiths C, Kunst H.

BMC Public Health. 2019 Nov 29;19(1):1598. doi: 10.1186/s12889-019-7983-7.

5.

Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.

Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O'Connell AM, Mirza A, Kon OM, Lalvani A, Zenner D.

Lancet Infect Dis. 2019 Nov;19(11):1191-1201. doi: 10.1016/S1473-3099(19)30260-9. Epub 2019 Aug 27.

6.

Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.

Abbott S, Christensen H, Lalor MK, Zenner D, Campbell C, Ramsay ME, Brooks-Pollock E.

Vaccine. 2019 Aug 14;37(35):5067-5072. doi: 10.1016/j.vaccine.2019.06.056. Epub 2019 Jul 8.

PMID:
31296375
7.

Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study.

Gupta RK, Rosenberg G, Eriksen J, Lipman M, Jackson C, Roy A, Zenner D, Smith C, Harber M, Campbell C, Abubakar I.

Eur Respir J. 2019 Oct 17;54(4). pii: 1802245. doi: 10.1183/13993003.02245-2018. Print 2019 Oct. No abstract available.

PMID:
31248953
8.

Nutritional profile of Syrian refugee children before resettlement.

Pernitez-Agan S, Wickramage K, Yen C, Dawson-Hahn E, Mitchell T, Zenner D.

Confl Health. 2019 Jun 4;13:22. doi: 10.1186/s13031-019-0208-y. eCollection 2019.

9.

Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.

Collin SM, Wurie F, Muzyamba MC, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir Rev. 2019 May 29;28(152). pii: 180107. doi: 10.1183/16000617.0107-2018. Print 2019 Jun 30.

10.

Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.

Berrocal-Almanza LC, Botticello J, Piotrowski H, Karnani N, Kon OM, Lalvani A, Zenner D.

Int J Tuberc Lung Dis. 2019 May 1;23(5):563-570. doi: 10.5588/ijtld.18.0230.

11.

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.

Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, Marchese V, Matteelli A, Menezes D, Zenner D, Hergens MP.

Int J Infect Dis. 2019 Mar;80S:S45-S49. doi: 10.1016/j.ijid.2019.02.041. Epub 2019 Feb 28.

12.

Million Migrants study of healthcare and mortality outcomes in non-EU migrants and refugees to England: Analysis protocol for a linked population-based cohort study of 1.5 million migrants.

Burns R, Pathak N, Campos-Matos I, Zenner D, Vittal Katikireddi S, Muzyamba MC, Miranda JJ, Gilbert R, Rutter H, Jones L, Williamson E, Hayward AC, Smeeth L, Abubakar I, Hemingway H, Aldridge RW.

Wellcome Open Res. 2019 Jan 17;4:4. doi: 10.12688/wellcomeopenres.15007.1. eCollection 2019.

13.

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.

Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, Mandelbaum M, Matteelli A, Migliori GB, Oordt-Speets A, Solovic I, Vašáková M, Verver S, de Vlas SJ, Vonk Noordegraaf-Schouten MJM, de Vries G, Zenner D, van der Werf MJ.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802077. doi: 10.1183/13993003.02077-2018. Print 2019 Jan. No abstract available.

PMID:
30655449
14.

Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.

Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801449. doi: 10.1183/13993003.01449-2018. Print 2018 Dec.

PMID:
30309977
15.

Transmission of toxigenic Corynebacterium diphtheriae by a fully immunised resident returning from a visit to West Africa, United Kingdom, 2017.

Edwards D, Kent D, Lester C, Brown CS, Murphy ME, Brown NM, Sule O, Itani A, Chand M, Trindall A, Pearson C, Roddick I, Fry NK, Hoffmann J, Iyanger N, Kemp L, White J, Javid B, Ramsay ID, Zenner D, Ahmed A, Amirthalingam G, Salimee S, Litt D, Reacher M.

Euro Surveill. 2018 Sep;23(39). doi: 10.2807/1560-7917.ES.2018.23.39.1700681. Erratum in: Euro Surveill. 2018 Oct;23(42):.

16.

Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study.

Crawshaw AF, Pareek M, Were J, Schillinger S, Gorbacheva O, Wickramage KP, Mandal S, Delpech V, Gill N, Kirkbride H, Zenner D.

BMC Med. 2018 Aug 28;16(1):143. doi: 10.1186/s12916-018-1125-4.

17.

Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland.

Winter JR, Stagg HR, Smith CJ, Lalor MK, Davidson JA, Brown AE, Brown J, Zenner D, Lipman M, Pozniak A, Abubakar I, Delpech V.

BMC Med. 2018 Jun 7;16(1):85. doi: 10.1186/s12916-018-1070-2.

18.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

19.

Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study.

Thomas HL, Harris RJ, Muzyamba MC, Davidson JA, Lalor MK, Campbell CNJ, Anderson SR, Zenner D.

Thorax. 2018 Aug;73(8):769-775. doi: 10.1136/thoraxjnl-2017-211074. Epub 2018 Apr 19.

PMID:
29674389
20.

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.

Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, van der Werf MJ, Noori T, Pottie K, Matteelli A, Zenner D, Morton RL.

Euro Surveill. 2018 Apr;23(14). doi: 10.2807/1560-7917.ES.2018.23.14.17-00543.

21.

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.

Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, Noori T, van der Werf MJ, Pottie K, Matteelli A, Zenner D, Morton RL.

Euro Surveill. 2018 Apr;23(14). doi: 10.2807/1560-7917.ES.2018.23.14.17-00542.

22.

Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.

Davidson JA, Fulton N, Thomas HL, Lalor MK, Zenner D, Brown T, Murphy S, Anderson LF.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):252-257. doi: 10.5588/ijtld.17.0620.

PMID:
29471901
23.

National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area.

Loutet MG, Burman M, Jayasekera N, Trathen D, Dart S, Kunst H, Zenner D.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701226. doi: 10.1183/13993003.01226-2017. Print 2018 Jan.

24.

Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems.

Pottie K, Mayhew AD, Morton RL, Greenaway C, Akl EA, Rahman P, Zenner D, Pareek M, Tugwell P, Welch V, Meerpohl J, Alonso-Coello P, Hui C, Biggs BA, Requena-Méndez A, Agbata E, Noori T, Schünemann HJ.

BMJ Open. 2017 Sep 11;7(9):e014608. doi: 10.1136/bmjopen-2016-014608.

25.

Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.

Zenner D, Hafezi H, Potter J, Capone S, Matteelli A.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):965-976. doi: 10.5588/ijtld.16.0935. Review.

PMID:
28826445
26.

Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.

Kunst H, Burman M, Arnesen TM, Fiebig L, Hergens MP, Kalkouni O, Klinkenberg E, Orcau À, Soini H, Sotgiu G, Zenner D, de Vries G.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):840-851. doi: 10.5588/ijtld.17.0036. Review.

PMID:
28786791
27.

Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.

Zenner D, Beer N, Harris RJ, Lipman MC, Stagg HR, van der Werf MJ.

Ann Intern Med. 2017 Aug 15;167(4):248-255. doi: 10.7326/M17-0609. Epub 2017 Aug 1. Review.

28.

Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.

Zenner D, Loutet MG, Harris R, Wilson S, Ormerod LP.

Eur Respir J. 2017 Jul 27;50(1). pii: 1602505. doi: 10.1183/13993003.02505-2016. Print 2017 Jul.

29.

Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.

Douglas P, Posey DL, Zenner D, Robson J, Abubakar I, Giovinazzo G.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):737-745. doi: 10.5588/ijtld.17.0019.

PMID:
28633697
30.

Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.

Usdin M, Dedicoat M, Gajraj R, Harrison P, Kaur H, Duffield K, Walker CL, Akram Y, Aiyedun V, Mohamed H, Zenner D.

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):175-180. doi: 10.5588/ijtld.16.0398.

PMID:
28234081
31.

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.

Davidson JA, Loutet MG, O'Connor C, Kearns C, Smith RM, Lalor MK, Thomas HL, Abubakar I, Zenner D.

Emerg Infect Dis. 2017 Mar;23(3):377-386. doi: 10.3201/eid2303.161408.

32.

Crisis-Affected Populations and Tuberculosis.

Zenner D.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0031-2016. Review.

PMID:
28155816
33.

Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.

Aldridge RW, Zenner D, White PJ, Williamson EJ, Muzyamba MC, Dhavan P, Mosca D, Thomas HL, Lalor MK, Abubakar I, Hayward AC.

Lancet. 2016 Nov 19;388(10059):2510-2518. doi: 10.1016/S0140-6736(16)31008-X. Epub 2016 Oct 11.

34.

Diagnosis of Latent Tuberculosis Infection in HIV-infected Pregnant Women. "Baby Steps" toward Better Tuberculosis Control in Pregnancy.

Zenner D, Ashkin D.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1332-3. doi: 10.1164/rccm.201601-0156ED. No abstract available.

PMID:
27304241
35.

Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study.

Aldridge RW, Zenner D, White PJ, Muzyamba MC, Loutet M, Dhavan P, Mosca D, Hayward AC, Abubakar I.

Lancet Infect Dis. 2016 Aug;16(8):962-70. doi: 10.1016/S1473-3099(16)00072-4. Epub 2016 Mar 21.

36.

The impact of migration on tuberculosis epidemiology and control in high-income countries: a review.

Pareek M, Greenaway C, Noori T, Munoz J, Zenner D.

BMC Med. 2016 Mar 23;14:48. doi: 10.1186/s12916-016-0595-5. Review.

37.

Tackling the public health needs of refugees.

Campos-Matos I, Zenner D, Smith G, Cosford P, Kirkbride H.

BMJ. 2016 Feb 17;352:i774. doi: 10.1136/bmj.i774. No abstract available.

PMID:
26888825
38.

Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland.

Gupta RK, Rice B, Brown AE, Thomas HL, Zenner D, Anderson L, Pedrazzoli D, Pozniak A, Abubakar I, Delpech V, Lipman M.

Lancet HIV. 2015 Jun;2(6):e243-51. doi: 10.1016/S2352-3018(15)00063-6. Epub 2015 May 17.

PMID:
26423197
39.

Treating latent TB in primary care: a survey of enablers and barriers among UK General Practitioners.

Atchison C, Zenner D, Barnett L, Pareek M.

BMC Infect Dis. 2015 Aug 13;15:331. doi: 10.1186/s12879-015-1091-9.

40.

'Pre-entry screening for tuberculosis' commentary: authors' response.

Aldridge RW, Yates TA, Zenner D, White PJ, Abubakar I, Hayward AC.

Pathog Glob Health. 2015 Jun;109(4):166-7. doi: 10.1179/2047772415Z.000000000278. No abstract available.

41.

CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.

Gupta RK, Brown AE, Zenner D, Rice B, Yin Z, Thomas HL, Pozniak A, Abubakar I, Delpech V, Lipman M.

AIDS. 2015 Jul 17;29(11):1363-8. doi: 10.1097/QAD.0000000000000685.

PMID:
26091298
42.

Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland.

Zenner D, Abubakar I, Conti S, Gupta RK, Yin Z, Kall M, Kruijshaar M, Rice B, Thomas HL, Pozniak A, Lipman M, Delpech V.

Thorax. 2015 Jun;70(6):566-73. doi: 10.1136/thoraxjnl-2014-206452. Epub 2015 Mar 24.

PMID:
25805209
43.

Treatment of latent tuberculosis infection.

Zenner D, Stagg HR, Harris RJ, Abubakar I.

Ann Intern Med. 2015 Mar 3;162(5):394-5. doi: 10.7326/L15-5058-3. No abstract available.

PMID:
25732295
44.

A collaborative strategy to tackle tuberculosis in England.

Abubakar I, Thomas HL, Morgan M, Anderson S, Zenner D, Cosford P.

Lancet. 2015 Jan 24;385(9965):312-3. doi: 10.1016/S0140-6736(14)61638-X. Epub 2015 Jan 19. No abstract available.

PMID:
25608753
45.

Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis.

Aldridge RW, Yates TA, Zenner D, White PJ, Abubakar I, Hayward AC.

Lancet Infect Dis. 2014 Dec;14(12):1240-9. doi: 10.1016/S1473-3099(14)70966-1. Epub 2014 Nov 7. Review.

46.

Treatment of latent tuberculosis infection: a network meta-analysis.

Stagg HR, Zenner D, Harris RJ, Muñoz L, Lipman MC, Abubakar I.

Ann Intern Med. 2014 Sep 16;161(6):419-28. doi: 10.7326/M14-1019. Review.

PMID:
25111745
48.

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.

Anderson LF, Tamne S, Brown T, Watson JP, Mullarkey C, Zenner D, Abubakar I.

Lancet Infect Dis. 2014 May;14(5):406-15. doi: 10.1016/S1473-3099(14)70022-2. Epub 2014 Mar 4.

49.

Reversing the tide of the UK tuberculosis epidemic.

Zenner D, Zumla A, Gill P, Cosford P, Abubakar I.

Lancet. 2013 Oct 19;382(9901):1311-2. doi: 10.1016/S0140-6736(13)62113-3. No abstract available.

PMID:
24139110
50.

Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats.

Li Y, Li L, Stephens MJ, Zenner D, Murray KC, Winship IR, Vavrek R, Baker GB, Fouad K, Bennett DJ.

J Neurophysiol. 2014 Jan;111(1):145-63. doi: 10.1152/jn.00508.2013. Epub 2013 Sep 25.

Supplemental Content

Loading ...
Support Center